Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

NCT00004286 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

NIH

Sponsor class

Conditions

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Interventions

DRUG: immune globulin

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]